L9 - Tx of Stable angina Flashcards

1
Q

Drug therapy for tx of stable angina (4)

A
  1. Aspirin
  2. nitrates
  3. Ca blockers
  4. beta blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

• One tablet (81-325 mg/day) leads to fewer cardiac events and increased survival

Often Given in an Enteric-Coated Form

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Kinds of life style modification for stable angina

A

smoking
diet
lipids
exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which is false regarding nitrates?

a) sublingual. NTG prn (i.e. as needed) and prophylactically
b) maintenance therapy with isosorbide dinitrate (3x/d) or mononitrate (1/d)
c) no tolerance problems

A

C - tolerance develops if given for 24hrs/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the 3 families of Ca blockers

A
  1. verapamil
  2. Diltiazem
  3. Dihydropyridines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which Ca blocker (s):

  • decreases HR/AVN and
  • decreases contractility
A

Verapamil and diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which Ca blocker does not seem to depress cardiac function, HR or AV conduction?

A

Dihydropyridines (nifedipine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which drug is a ultra long acting calcium blocker (dihydropyridine family)?

A

Amlodipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors to consider when selecting beta blockers (4)

A
  1. B1 selectivity (esmolol, metoprolol, atenolol) or not (propranolol, carvedilol, labetalol)
  2. long acting (atenolol) or short acting (metoprolol, propranolol, carvedilol, labetalol) or ultrashort acting (esmolol)
  3. Alpha 1 blocking property (carvedilol, labetalol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which drug, when started in the hours to days after an acute M.I., they reduce frequency of recurrent infarctions and cardiac deaths over the next months and years!

A

Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type of selectivity of:

  • esmolol
  • metoprolol,
  • atenolol
A

B1 selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Type of selectivity of:

  • propranolol
  • carvedilol
  • labetalol
A

non-b1 selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How fast does atenolol act as a beta blocker?

A

long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How fast does metoprolol, propranolol, carvediolol and labetalol act as a beta blockers?

A

short acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How fast does esmolol act as a beta blocker?

A

ultrashort acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which is not a alpha 1 blocker?

  • carevdilol
  • propranolol
  • labetalol
A

propranolol

17
Q

When is revascularization indicated in patients with stable angina?

A
  1. For medically refractory angina or as an alternative to primary medical treatment
  2. For improved survival: CABG for patients with:
    a) left main stenosis, or
    b) 3 vessel coronary disease with:
    (i) decreased ventricular systolic function or
    (ii) marked severe angina by history or treadmill testing, or
    c) proximal anterior descending and circumflex stenoses with decreased L.V.
    function.
18
Q

2 types of resvasculazation techniques

A
  1. Coronary artery bypass grafting (CABG)
  2. Percutaneous coronary interventions (PCI) at time of cardiac catheterization (e.g.
    angioplasty often with placement of coronary stent; atherectomy)
19
Q

What do you do If medical therapy beyond risk factor management & ASA is chosen for Tx of stable angina:

A

A. Initiate treatment with single drug either from beta blocker or vasodilator class (either
calcium blocker or nitrate group). Titrate up to maximally tolerated dose (or evidence of
complete “beta-blockade”, i.e. max. HR on exercise ≤ 100-120) or resolution of the angina.
B. If angina still significantly disabling to the patient, add a second drug from the other group,
i.e., beta blocker or vasodilator group, and titrate to maximal amount.
C. If angina is still significantly disabling to the patient, consider catheterization to assess
feasibility of some form of revascularization.
D. In addition to the patient’s history at follow-up visits, repeat treadmill testing on meds can
be useful to assess the efficacy of the medications and the degree of beta-blockade.
E. Start ACE-Inhibitor (⇒ ↓ deaths,MI’s&CVA’s even without CHF or ↑BP present) (except
possibly those with no hypertension, diabetes mellitus, renal disease, or left ventricular
systolic dysfunction and with well controlled cholesterol values)